The China Endoscope Reprocessing Market was valued at $47.2 Million in 2025 and projected to reach to $81.3 Million by 2030, representing a compound annual growth rate of 11.5%. China's endoscope reprocessing market is positioned for sustained growth through 2030, driven by continuous healthcare modernization and increased government funding for medical infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China's endoscope reprocessing market is valued at $47.2 million in 2025, with projections reaching $81.3 million by 2030, representing a robust 11.5% CAGR that outpaces the global average of 9.4%.
Rapid expansion of hospital networks and surgical centers across China's tier-2 and tier-3 cities is driving demand for standardized endoscope reprocessing solutions and infection control protocols.
Increasingly stringent Chinese healthcare regulations and infection prevention standards are compelling healthcare facilities to adopt advanced reprocessing technologies and automated systems.
Growing emphasis on patient safety and cross-contamination prevention in Chinese hospitals is accelerating adoption of high-level disinfection and sterilization equipment for endoscopic instruments.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | FLEXIBLE ENDOSCOPES (Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 9.4% from 2025 to 2030 |
| Largest Segment | HOSPITALS & ASCS (End User) |
| Market Size Base Year (Billions) | ~USD 2.71 (2025) |
| Revenue Forecast (Billions) | ~USD 4.24 (2030) |
| Segments Covered | Product, Type, Portability, Type Of Endoscope, End User |
5 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HOSPITALS & ASCS | 116.1 | 129.8 | 145.3 | 162.8 | 182.8 | 205.5 | 231.4 | 260.9 | 12.4 |
| OTHER END USERS | 9.4 | 10.3 | 11.3 | 12.4 | 13.7 | 15.1 | 16.7 | 18.4 | 10.3 |
| SPECIALTY CLINICS | 20.6 | 22.8 | 25.2 | 28 | 31.1 | 34.6 | 38.5 | 43 | 11.2 |
| TOTAL | 146.1 | 162.9 | 181.8 | 203.2 | 227.6 | 255.2 | 286.6 | 322.3 | 12.1 |
China's endoscope reprocessing market is valued at $47.2 million in 2025 and is projected to reach $81.3 million by 2030.
China's endoscope reprocessing market is growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2030.
China's market growth is driven by healthcare infrastructure expansion, stricter regulatory standards for sterilization, increased awareness of infection control, and rising adoption of advanced reprocessing technologies.
China's endoscope reprocessing market is growing at 11.5% CAGR, which exceeds the global average of 9.4%, indicating faster market expansion in China.
China's endoscope reprocessing market is forecast to reach $81.3 million by 2030, representing a $34.1 million increase from the 2025 baseline of $47.2 million.
The study involved key activities in estimating the current market size for the endoscope reprocessing market. Extensive secondary research was conducted to gather information on this sector. The next step was to validate these findings, assumptions, and size estimates with industry experts across the value chain through primary research. Different approaches, such as top-down and bottom-up methods, were used to calculate the total market size. Subsequently, market segmentation and data triangulation techniques were applied to estimate the size of various segments and subsegments within the endoscope reprocessing market.
The four steps involved in estimating the market size are:
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global endoscope reprocessing market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
During the primary research process for the endoscope reprocessing market, various stakeholders from both supply and demand sides were interviewed to gather qualitative and quantitative insights. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, product development managers, and heads of technology and innovation from leading companies offering endoscope reprocessing equipment, consumables, and tracking systems. On the demand side, respondents included infection control specialists, hospital procurement officers, sterilization technicians, and representatives from ambulatory surgical centers (ASCs), specialty clinics, and hospitals. The primary research aimed to validate the segmentation framework, identify key players and their strategies, and understand current and emerging trends, challenges, and market dynamics impacting the endoscope reprocessing industry.
The following is a breakdown of the primary respondents:
Note 1: Other designations include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were determined based on revenue mapping of leading product manufacturers and OEMs active in the worldwide endoscope reprocessing market. All key service providers were identified at the global, national, and/or national/regional levels. Revenue mapping for the respective business segments and sub-segments was conducted for the major players. The global endoscope reprocessing market was split into various segments and subsegments based on:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
The research methodology used to estimate the market size includes the following:

After determining the overall market size using the process outlined above, the total market was divided into several segments. To complete the market engineering process and obtain precise data for all segments and subsegments, data triangulation and market breakdown methods were used wherever applicable. The data was triangulated by examining various factors and trends from both the demand and supply sides.
Endoscope reprocessing involves cleaning, high-level disinfection, or sterilization of reusable endoscopes to ensure safe reuse and prevent cross-contamination. The market includes automated reprocessing equipment (such as automated endoscope reprocessors (AER) and endoscope drying, storage, and transport systems), consumables (such as detergents, wipes, and disinfectants), and tracking systems that help maintain compliance with infection control standards. These solutions are essential for reducing healthcare-associated infections (HAIs) and are commonly used across hospitals, ambulatory surgical centers, and specialty settings clinics.
Full forecast, segment splits, and company analysis for all Endoscope Reprocessing Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report